Invivoscribe at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Invivoscribe brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 637. Its session walks the measurable residual disease workflow from nucleic acid extraction through detection. The company makes assay kits for blood cancers and runs the LabPMM laboratory network for standardized flow cytometry and molecular testing.
| Organization | AMP 2026 Attendance |
|---|---|
Invivoscribe San Diego, CA | |
Diagnostics for hematologic malignancies: assay kits plus the LabPMM laboratory network offering standardized flow cytometry and molecular testing and companion diagnostic development. | Booth Exhibiting at Booth 637 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 4:00pm–4:50pm From Extraction to Detection: Optimizing MRD Testing Workflows Nucleic acid extraction, concentration and quantification automated upstream of residual disease testing in blood cancers. |
Instantly find 20 buyers from Invivoscribe
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction